Abstract
The coronavirus disease 2019 (COVID-19) pandemic will transition into endemic phase with perpetual risk of severe disease and high mortality in vulnerable people - the elderly and those with co-morbidities, unless eradicated. Although several vaccines are already available to rich countries, low-income countries face gross vaccine inequity. We propose COVID-19 eradication to address both problems. An eradication program will ensure vaccine equity and international cooperation to establish public health surveillance and high quality laboratory diagnostic services in all countries. Eradication is biologically and technically feasible. We hope the World Health Organization will accept the proposition and design the necessary strategy without delay.
Keywords: Herd effect, Herd immunity, SARS-CoV-2
Footnotes
Funding
None
Competing interests
None stated.
References
- 1.Hodgens A, Gupta V. Severe Acute Respiratory Syndrome. In: StatPearls [Internet]. StatPearls Publishing; 2021. Accessed May 10, 2021. Available from: https://www.ncbi.nlm.nih.gov/books/NBK558977/ [PubMed]
- 2.Smith R. Did we eradicate SARS? Lessons learned and the way forward. American Journal of Biomedical Science and Reserch. 2019;6:AJBSR.MS.ID.001017.
- 3.World Health Organization. WHO Coronavirus (Covid-19) Dashboard. Accessed May 11, 2021. Available from: https://covid19.who.int/
- 4.World Health Organization. Covax. Accessed May 11, 2021. Available from: https://www.who.int/initiatives/act-accelerator/covax
- 5.The Independent Panel for Pandemic Preparedness & Response. Main Report. COVID-19: Make it the last pandemic. 2021;42–43. Accessed 20 May, 2021. Available from: theindependentpanel.org/documents-linked-to-co-chairs-presentation-of-findings-and-recommendations/
- 6.John TJ. Will coronavirus pandemic eventually evolve as pan-endemic? Current Science. 2020;118:855–56. doi: 10.18520/cs/v118/i3/376-382. [DOI] [Google Scholar]
- 7.Dowdle WR. The principles of disease elimination and eradication. Bull World Health Organ. 1998;76:23–5. [PMC free article] [PubMed] [Google Scholar]
- 8.Lee BY, Bartsch SM, Ferguson MC, et al. The value of decreasing the duration of the infectious period of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. PLoS Comput Biol. 2021;17:e1008470. doi: 10.1371/journal.pcbi.1008470. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Lesham E, Lopman BA. Population immunity and vaccine protection against infection. Lancet. 2021;397:1686–87. doi: 10.1016/S0140-6736(21)00870-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.John TJ, Samuel R. Herd immunity and herd effect: new insights and definitions. Eur J Epidemiol. 2000;16:601–6. doi: 10.1023/A:1007626510002. [DOI] [PubMed] [Google Scholar]
- 11.Leshem E, Wilder-Smith A. COVID-19 vaccine impact in Israel and a way out of the pandemic. Lancet. 2021:S0140-6736(21)01018-7. [DOI] [PMC free article] [PubMed]
- 12.Vavrek D, Speroni L, Curnow KJ, et al. Genomic surveillance at scale is required to detect newly emerging strains at an early time point [pre-print]. medRxiv 2021.01.12.21249613.
- 13.John TJ, Dharmapalan D. The time to begin plans for COVID-19 eradication is now. Christ Journal of Global Health. 2020;7.
- 14.Johansen MD, Irving A, Montagutelli X, et al. Animal and translational models of SARS-CoV-2 infection and COVID-19. Mucosal Immunol. 2020;13:877–91. doi: 10.1038/s41385-020-00340-z. [DOI] [PMC free article] [PubMed] [Google Scholar]